Cited by 26Regulation of Appetite and ObesityCholesterol and Lipid MetabolismAdipokines, Inflammation, and Metabolic Diseases

IDOL regulates systemic energy balance through control of neuronal VLDLR expression

Open access
Lee, Stephen D., Priest, Christina, Bjursell, Mikael, Gao, Jie, Arneson, Douglas V., Ahn, In Sook, Diamante, Graciel, van Veen, J. Edward +22 more·2019·Nature Metabolism

Abstract

Liver X receptors limit cellular lipid uptake by stimulating the transcription of Inducible Degrader of the LDL Receptor (IDOL), an E3 ubiquitin ligase that targets lipoprotein receptors for degradation. The function of IDOL in systemic metabolism is incompletely understood. Here we show that loss of IDOL in mice protects against the development of diet-induced obesity and metabolic dysfunction by altering food intake and thermogenesis. Unexpectedly, analysis of tissue-specific knockout mice revealed that IDOL affects energy balance, not through its actions in peripheral metabolic tissues (liver, adipose, endothelium, intestine, skeletal muscle), but by controlling lipoprotein receptor abundance in neurons. Single-cell RNA sequencing of the hypothalamus demonstrated that IDOL deletion altered gene expression linked to control of metabolism. Finally, we identify VLDLR rather than LDLR as the primary mediator of IDOL effects on energy balance. These studies identify a role for the neuronal IDOL-VLDLR pathway in metabolic homeostasis and diet-induced obesity.

AI snapshot

Written from the paper’s full text.

TL;DR

IDOL deficiency protects mice from diet-induced obesity and metabolic dysfunction by acting in neurons rather than peripheral metabolic tissues. The phenotype requires neuronal VLDLR, not LDLR, and is linked to altered hypothalamic gene expression, food intake, and thermogenesis.

Key findings

  • Global IDOL-knockout mice fed western diet for 15 weeks were 22% lighter than WT controls and averaged 11% body fat versus 32% in WT; they also showed improved glucose clearance and insulin tolerance.
  • Liver-, adipose-, endothelial-, intestine-, and muscle-specific IDOL deletions did not recapitulate the global knockout phenotype, indicating peripheral metabolic tissues are not the primary drivers.
  • IDOL–VLDLR double knockout mice were indistinguishable from VLDLR single knockouts and lost the protection seen with IDOL knockout, whereas IDOL–LDLR double knockout mice remained protected like IDOL knockouts, identifying VLDLR as the key mediator.
  • CNS IDOL knockdown via intracerebroventricular ASO suppressed hypothalamic *Idol* expression by 65%, increased VLDLR protein, reduced weight after six weeks on diet (p<0.01), and increased energy expenditure; pan-neuronal IDOL knockout reduced food intake and adiposity.

Methods

  • Mouse models included global IDOL knockouts from two independent lines, tissue-specific conditional knockouts (liver, adipose, endothelium, intestine, skeletal muscle, neurons), an adipose-specific dominant-active IDOL transgenic line, and IDOL–LDLR or IDOL–VLDLR double knockouts.
  • Mice were challenged with chow, low-fat, high-fat, western, or high-fat/high-cholesterol diets; body mass, adiposity by MRI/DEXA, glucose and insulin tolerance, food intake, thermoneutrality, indirect calorimetry, histology, and western blotting were assessed.
  • Hypothalamic single-cell RNA sequencing used Drop-seq; clustering identified 26 cell populations, including 15 neuronal populations, from 11,453 single cells, with differential expression tested by Wilcoxon rank sum test.

Limitations

  • The paper states that specific hypothalamic regions responsible for the IDOL effect were not identified; viral-Cre deletion in ARC, VMH, or PVH did not recapitulate the neuronal knockout phenotype, and the authors note the viral-Cre approach may affect multiple neuronal populations.
  • The paper states that acute CNS ASO knockdown did not show changes in food intake during a two-week evaluation, possibly due to acute versus chronic deletion or study duration.
  • Evident from the text: most subsequent studies used male mice because females were resistant to diet-induced obesity, and the mechanistic ligand linking neuronal VLDLR to peripheral energy balance remains unresolved.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s42255-019-0127-7

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

18 of 33 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    IDOL controls the abundance of LDLR, VLDLR, and ApoER2 via ubiquitination, which targets the proteins for lysosomal degradation.

    “IDOL controls the abundance of three proteins (LDLR, VLDLR, and ApoER2) via ubiquitination, which targets the proteins for lysosomal degradation9,13.”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [9] Hong, C. et al. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J. Biol. Chem. 285, 19720–19726 (2010). source
    • cites [13] Calkin, A. C. et al. FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors. Proc. Natl Acad. Sci. USA 108, 20107–20112 (2011). source
  • Premisecitation

    VLDLR-KO mice exhibited a reduction in mass and BMI relative to WT controls on a mixed background.

    “One of the initial observations made by Herz and colleagues when they developed the VLDLR-KO mice was that the mice exhibited a reduction in mass and BMI relative to WT controls on a mixed background27.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [27] Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L. & Herz, J. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 92, 8453–8457 (1995). source

      The Abstract reports that the authors produced VLDLR-knockout mice and detected a modest decrease in body weight and body mass index. Our copy does not specify a mixed genetic background or explicitly identify wild-type controls for that comparison. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Study design and conductcitation

    The viral-Cre approach used here suffers from the inherent weakness that the SynI promoter-driven Cre will be expressed in all infected neurons, which might affect the role of specific neuronal populations.

    “We acknowledge that the viral-Cre approach used here suffers from the inherent weakness that the SynI promoter-driven Cre will be expressed in all infected neurons, which might might the role of specific neuronal populations51.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [51] Mancini, G. & Horvath, T. L. Viral vectors for studying brain mechanisms that control energy homeostasis. Cell Metab. 27, 1168–1175 (2018). source

      The supplied passage has no section or page label and contains only reference links, not discussion of the viral-Cre approach. Searches for SynI, promoter-driven Cre expression, and neuronal specificity found no substantive passage in our copy that addresses the claim. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • Premisecitation

    Whole-body deletion of VLDLR is protective against diet-induced obesity.

    “Whole body deletion of VLDLR has previously been shown to be protective against diet-induced obesity22,27,28.”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [22] Goudriaan, J. R. et al. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481 (2004). source
    • cites [27] Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L. & Herz, J. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 92, 8453–8457 (1995). source

      The Abstract reports that mice lacking VLDL receptors had modestly lower body weight, body mass index, and adipose tissue mass. It mentions high-fat feeding but does not report that deletion specifically protected against diet-induced obesity, so the diet-specific claim goes beyond the passage. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [28] Goudriaan, J. R. et al. Protection from obesity in mice lacking the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 21, 1488–1493 (2001). source
  • Findingown data

    18-month-old chow-fed IDOL-KO mice are protected against age-induced obesity even on standard chow diet.

    “18-month old chow-fed IDOL-KO mice (developed at UCLA) demonstrated that deletion of IDOL protected against age-induced obesity, even when the mice were fed standard chow diet”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. 25
  • May combine two claims. 16
  • The quote only partly states this claim. 1
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ApoE and ApoJ are known ligands for VLDLR.

    “Both ApoE and ApoJ (also called Clusterin)–two apolipoproteins found in cerebrospinal fluid–are known ligands for VLDLR26,53,54.”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [26] Andersen, O. M. et al. Essential role of the apolipoprotein E receptor-2 in sperm development. J. Biol. Chem. 278, 23989–23995 (2003). source
    • cites [53] Leeb, C., Eresheim, C. & Nimpf, J. Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway. J. Biol. Chem. 289, 4161–4172 (2014). source

      The Discussion (page unavailable) states that clusterin binds VLDLR, supporting the ApoJ portion of the claim. The passage comparing VLDLR with the LDL receptor names ApoE as a ligand of the LDL receptor, not VLDLR; no retrieved passage establishes ApoE as a VLDLR ligand. The retrieved passages also do not establish that both proteins are found in cerebrospinal fluid. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [54] Pohlkamp, T., Wasser, C. R. & Herz, J. Functional roles of the interaction of APP and lipoprotein receptors. Front Mol. Neurosci. 10, 54 (2017). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Several non-apolipoprotein ligands have been proposed for VLDLR, including Reelin and F-spondin.

    “Several non-apolipoprotein ligands have also been proposed for VLDLR, including Reelin2 and F-spondin55.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [2] Trommsdorff, M. et al. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689–701 (1999). source
    • cites [55] Zisman, S. et al. Proteolysis and membrane capture of F-spondin generates combinatorial guidance cues from a single molecule. J. Cell Biol. 178, 1237–1249 (2007). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In the periphery, VLDLR has a clear role facilitating lipolytic activity of LPL.

    “In the periphery, VLDLR has a clear role facilitating lipolytic activity of LPL20,22”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [20] Yagyu, H. et al. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277, 10037–10043 (2002). source
    • cites [22] Goudriaan, J. R. et al. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481 (2004). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Energy expenditure data from indirect calorimetry were analyzed using two methods: NIDDK MMPC regression and CalR analysis of covariance.

    “The energy expenditure data generated by the indirect calorimetry experiment were analyzed using two methods: 1. the NIDDK Mouse Metabolic Phenotyping Centers using their energy expenditure analysis page (http://www.mmpc.org/shared/regression.aspx) and 2. the R programming language with CalR, a custom package for analysis of indirect calorimetry using analysis of covariance with a graphical user”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [31] Mina, A. I. et al. CalR: a web-based analysis tool for indirect calorimetry experiments. Cell Metab. 28, 656–666 (2018). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Free fatty acid sensing by the hypothalamus is a well-established modulator of neuronal activity, affecting peripheral metabolism.

    “Free fatty acid sensing by the hypothalamus is a well-established modulator of neuronal activity57, affecting peripheral metabolism58–60”
    Quote in the paperNot a substantial claim1 of 4 sources checked
    • cites [57] Oomura, Y., Nakamura, T., Sugimori, M. & Yamada, Y. Effect of free fatty acid on the rat lateral hypothalamic neurons. Physiol. Behav. 14, 483–486 (1975). source
    • cites [58] Lam, T. K. T. et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11, 320–327 (2005). source
    • cites [59] Lam, T. K. T., Schwartz, G. J. & Rossetti, L. Hypothalamic sensing of fatty acids. Nat. Neurosci. 8, 579–584 (2005). source
    • cites [60] Yue, J. T. Y. et al. A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins. Nat. Commun. 6, 5970 (2015). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Prior studies showed that the IDOL pathway in the CNS affects the function of both microglia and neurons.

    “Prior studies showed that the IDOL pathway in the CNS affects the function of both microglia and neurons29,30”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [29] Choi, J. et al. The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis. Sci. Transl. Med. 7, 314ra184 (2015). source

      The Results section, “Loss of Idol facilitates ApoE and Aβ uptake and clearance” (page unavailable), shows that Idol regulates Aβ uptake in primary microglia and that Idol knockdown increases uptake in a neuronal cell line. It also reports no change in Aβ uptake in primary mouse neurons lacking Idol, so the broad claim about neuronal function needs that qualification. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [30] Gao, J. et al. The E3 ubiquitin ligase IDOL regulates synaptic ApoER2 levels and is important for plasticity and learning. eLife 6, 1741 (2017). source

      The Discussion reports that loss of IDOL impairs neuronal spine remodeling and the plasticity of neural circuits in vivo, supporting the neuronal part of the claim. The passages from our copy do not report an effect of the IDOL pathway on microglial function; a search for “microglia” found no such evidence. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Prior mechanistic analyses suggested that VLDLR in the periphery acts in the endothelium to enhance lipoprotein lipase-dependent hydrolysis of triglycerides.

    “Prior mechanistic analyses have suggested that VLDLR in the periphery acts in the endothelium to enhance lipoprotein lipase-dependent hydrolysis of triglycerides20–23.”
    Quote in the paperNot a substantial claim2 of 4 sources checked
    • cites [20] Yagyu, H. et al. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277, 10037–10043 (2002). source
    • cites [21] Garcia-Arcos, I. et al. Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology. J. Biol. Chem. 288, 14046–14058 (2013). source
    • cites [22] Goudriaan, J. R. et al. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481 (2004). source
    • cites [23] Obunike, J. C. et al. Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. J. Biol. Chem. 276, 8934–8941 (2001). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    AGRP neurons have been associated with the negative regulation of energy expenditure.

    “AGRP neurons have also been associated with the negative regulation of energy expenditure36–38.”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [36] Caron, A., Lee, S., Elmquist, J. K. & Gautron, L. Leptin and brain-adipose crosstalks. Nat. Rev. Neurosci. 19, 153–165 (2018). source
    • cites [37] Kong, D. et al. GABAergic RIP-Cre neurons in the arcuate nucleus selectively regulate energy expenditure. Cell 151, 645–657 (2012). source
    • cites [38] Ruan, H.-B. et al. O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat. Cell 159, 306–317 (2014). source
  • May combine two claims.

    Findingown data

    IDOL-KO mice on western diet had reduced hepatic lipid accumulation and smaller adipocytes in the inguinal white adipose tissue depot.

    “This was accompanied by reduced hepatic lipid accumulation and smaller adipocytes in the inguinal white adipose tissue depot”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    There were no differences in lean body mass, nasal to anal length, or body temperature attributable to genotype in IDOL-knockout mice.

    “There were no differences in lean body mass (Extended Data Fig. 1F), nasal to anal length (Extended Data Fig. 1G), or to body temperature attributable to genotype (Extended Data Fig. 1H).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    IDOL-KO and IDOL-LDLR DKO groups had improved glucose clearance and enhanced response to insulin relative to WT, while the IDOL-VLDLR DKO group was indistinguishable from WT.

    “Both the IDOL-KO and IDOL-LDLR DKO groups had improved glucose clearance and enhanced response to a bolus of insulin relative to the WT group; however, the IDOL-VLDLR DKO group was indistinguishable from the WT group.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Clustering analysis combined with expression profiling of a panel of marker genes discriminated 26 unique clusters of cells in the hypothalamus.

    “Clustering analysis combined with expression profiling of a panel of marker genes allowed us to discriminate 26 unique clusters of cells in the hypothalamus.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    aP2-IDOL transgenic mice fed WD for twelve weeks showed no differences in mass, adiposity, or glucose and insulin responses compared to littermate controls.

    “we observed no differences in mass between the aP2-IDOL Tg mice and their littermate controls fed WD for twelve weeks (Extended Data Fig. 3C). Accordingly, neither adiposity nor responses to glucose and insulin challenges were affected by the transgene (Extended Data Fig. 3D–3F).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Idol-knockdown mice had smaller white adipose tissue depots containing smaller adipocytes, but no obvious increase in multi-locular cells resembling beige adipocytes.

    “The Idol-knockdown mice also had smaller white adipose tissue depots containing smaller adipocytes, but we did not find an obvious increase in multi-locular cells resembling beige adipocytes”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    ASO-treated mice appeared to have increased carbohydrate metabolism, but no consistent change in fat oxidation was observed.

    “The ASO-treated mice appeared to have increased carbohydrate metabolism, but we did not observe a consistent change in fat oxidation”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Histological analysis of brown adipose tissue in ASO-treated mice revealed smaller cells with more abundant lipid droplets.

    “Histological analysis of brown adipose tissue revealed smaller cells with more abundant lipid droplets (Fig. 4E), consistent with increased energy expenditure.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Idol ASO-treated mice were leaner by MRI analysis and had smaller fat pads upon dissection.

    “Consistent with the whole-body knockout, the Idol ASO-treated mice were leaner by MRI analysis (Fig. 4D) and had smaller fat pads upon dissection”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Deletion of IDOL has a more pronounced protective effect on WT mice but no additional effect on the background of VLDLR deficiency.

    “has an even more pronounced protective effect on WT mice, but has no additional effect on the background of VLDLR deficiency.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    The ARC image shows GFP-positive cells demonstrating successful infection of neurons and is representative of the sixteen mice injected in the ARC study.

    “An image of the ARC showing GFP-positive cells to demonstrate successful infection of neurons; the image is representative of the sixteen mice injected in the ARC study.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    Deletion of IDOL from neurons protected mice against diet-induced obesity by reducing food intake while enhancing energy expenditure pathways.

    “our work with the SynI-Cre mice clearly demonstrated that deletion of IDOL from neurons protected mice against diet-induced obesity by reducing food intake while enhancing energy expenditure pathways.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Western blots shown are representative of many independent experiments conducted by two independent researchers.

    “This blot is representative of many independent experiments conducted by two independent researchers.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The western blot image is representative of many independent experiments.

    “The image is representative of many independent experiments.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    The acute nature of the ASO studies allowed detection of increased energy expenditure at a whole-organism level, linking IDOL in the CNS to peripheral energy homeostasis.

    “The acute nature of the ASO studies allowed us to detect increased energy expenditure at a whole-organism level, linking IDOL in the CNS to peripheral energy homeostasis.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    There is evidence that ApoJ can bind and modulate Leptin response in cell culture.

    “While there is evidence that ApoJ can bind and modulate Leptin response in cell culture56”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [56] Bajari, T. M., Strasser, V., Nimpf, J. & Schneider, W. J. A model for modulation of leptin activity by association with clusterin. FASEB J. 17, 1505–1507 (2003). source
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    The phenotype of the UCLA global IDOL KO mice is consistent between different vivarium conditions.

    “Nevertheless, we conclude that the phenotype of the UCLA global IDOL KO mice is consistent between different vivarium conditions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given

    IDOL forms a homodimer which recognizes a specific conserved amino acid sequence in its membrane-bound targets for recognition and ubiquitin transfer, and only three proteins have been identified that meet this criterion: LDLR, VLDLR, and ApoER2.

    “IDOL forms a homodimer which recognizes a specific conserved amino acid sequence in its membrane-bound targets for recognition and ubiquitin transfer. To date only three proteins have been identified that meet this stringent criterion: the LDL receptor and its two most closely-related family members, VLDL receptor and ApoER2.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Double knockout cohorts were arranged to maximize the number of littermate controls.

    “Each cohort in the double knockout studies was arranged to maximize the number of littermate controls.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The macroscopic images of adipose depots are representative of the ten mice per group in the ASO study.

    “These images are representative of the ten mice per group in the ASO study.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Acting via the sympathetic nervous system, the hypothalamus is a key effector of CNS influence on adipose tissue, including response to cold.

    “Acting via the sympathetic nervous system32,43,44. the hypothalamus is a key effector of CNS influence on adipose tissue, including response to cold.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [32] Cannon, B. & Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277–359 (2004). source
    • cites [43] Chechi, K., Carpentier, A. C. & Richard, D. Understanding the brown adipocyte as a contributor to energy homeostasis. Trends Endocrinol. Metab. 24, 408–420 (2013). source
    • cites [44] Bamshad, M., Song, C. K. & Bartness, T. J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 276, R1569–R1578 (1999). source
  • Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.

    Study design and conductreasoning

    All studies were performed with male mice.

    “All studies performed with male mice in climate-controlled facilities maintained on a 12h light/dark cycle constant temperature of 22°C with group housed mice, unless otherwise noted.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Female mice are resistant to diet-induced obesity and required prolonged challenges with more severe diets to elicit adiposity changes.
  • May combine two claims.

    Interpretationown data

    Increased VLDLR protein levels in the hypothalamus of both IDOL-KO and IDOL-ASO-treated mice suggest that this region likely contributes to IDOL's metabolic effects.

    “We observed increased VLDLR protein levels in hypothalamus of both the IDOL-KO mice and IDOL-ASO-treated mice, suggesting that this region likely contributes to IDOL’s metabolic effects.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Individual populations of neurons within a given hypothalamic nucleus may have opposing effects, as with POMC and AGRP neurons in the arcuate nucleus.

    “Individual populations of neurons within a given hypothalamic nucleus may have opposing effects, as with POMC and AGRP neurons in the arcuate nucleus52.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [52] Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J. & Baskin, D. G. Central nervous system control of food intake. Nature 404, 661–671 (2000). source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The liver histology images are representative of three mice per treatment group analyzed for histology.

    “These images are representative of three mice per treatment group that were analyzed for histology.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The western blot samples were repeated twice to assess reproducibility.

    “These samples were repeated twice to assess reproducibility.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All data except energy expenditure data were analyzed using GraphPad Prism v7 with a predetermined alpha value of 0.05.

    “All data except the Energy Expenditure data were analyzed using GraphPad Prism v7 with a predetermined alpha value of 0.05.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Mouse studies conducted at UCLA were reviewed and approved by the Chancellor's Animal Research Committee, and mouse studies conducted by AstraZeneca were approved by the Gothenburg Ethics Committee for Experimental Animals.

    “The mouse studies conducted at UCLA were reviewed and approved by the Chancellor’s Animal Research Committee. The mouse studied conducted by AstraZeneca were approved by Gothenburg Ethics Committee for Experimental Animals, license nr: 38–2011.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    The PVH image shows GFP-positive cells demonstrating successful infection of neurons and is representative of the seventeen mice injected in the PVH experiment.

    “An image of the PVH showing GFP-positive cells to demonstrate successful infection of neurons; the image is representative of the seventeen mice injected in the PVH experiment.”
    Quote in the paperNot a substantial claim
37 of 37
  • The paper relies on this without support.

    IDOL and its targets are expressed in a number of metabolically-active tissues other than liver.

    “IDOL and its targets are expressed in a number of metabolically-active tissues other than liver, but the physiological role of IDOL in systemic lipid metabolism remains poorly understood.”
  • The paper relies on this without support.

    The physiological role of IDOL in systemic lipid metabolism remains poorly understood.

    “IDOL and its targets are expressed in a number of metabolically-active tissues other than liver, but the physiological role of IDOL in systemic lipid metabolism remains poorly understood.”
  • The paper relies on this without support.

    The lipoprotein receptor(s) through which IDOL regulates metabolism are unknown.

    “Furthermore, the lipoprotein receptor(s) through which IDOL regulates metabolism are unknown.”
  • The paper relies on this without support.

    VLDLR is most highly expressed in the brain, muscle, fat, and the endothelium.

    “VLDLR is most highly expressed in the brain, muscle, fat, and the endothelium.”
  • The paper relies on this without support.

    The possibility that central actions of IDOL affect metabolism has not been addressed.

    “however, the possibility that central actions of IDOL affect metabolism has not been addressed.”
  • The paper relies on this without support.

    Female mice are resistant to diet-induced obesity and required prolonged challenges with more severe diets to elicit adiposity changes.

    “Pilot studies used both genders of mice; however, female mice are resistant to diet-induced obesity and required prolonged challenges with more severe diets to elicit adiposity changes.”
  • The paper relies on this without support.

    LDLR is the only IDOL target expressed in the liver.

    “LDLR is the only IDOL target expressed in the liver, further supporting the conclusion that the liver is not the primary driver of the global IDOL-KO phenotype.”
  • The paper relies on this without support.

    Infection of neurons with AAV-hSyn-GFP-Cre in the arcuate nucleus or paraventricular nucleus of the hypothalamus successfully deletes IDOL in those neurons.

    “An image of the ARC showing GFP-positive cells to demonstrate successful infection of neurons”
    “An image of the PVH showing GFP-positive cells to demonstrate successful infection of neurons”
8 of 8

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • ASO dose-response measurement time differs

    Minor

    The Results say whole-brain samples for the dose-response study were collected two weeks after injection, while the Extended Data caption says Idol expression was measured eight weeks after injection.

1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lee, S. D., Priest, C., Bjursell, M., Gao, J., Arneson, D. V., Ahn, I. S., Diamante, G., van Veen, J. E., Massa, M. G., Calkin, A. C., Kim, J., Andersén, H., Rajbhandari, P., Porritt, M., Carreras, A., Ahnmark, A., Seeliger, F., Maxvall, I., Eliasson, P., Althage, M., Åkerblad, P., Lindén, D., Cole, T. A., Lee, R., Boyd, H., Bohlooly-Y, M., Correa, S. M., Yang, X., Tontonoz, P., & Hong, C.
Affiliations
  • University of California, Los Angeles (US)
  • AstraZeneca (Sweden) (SE)
  • Ionis Pharmaceuticals (United States) (US)
  • AstraZeneca (United Kingdom) (GB)
Corresponding author
Tontonoz, Peter
Venue
Nature Metabolism
Published
2019-10-28
Volume
1
Issue
11
Pages
1089-1100
ISSN
2522-5812 (ISSN-L)
OpenAlex
W2981614517
Cited by
26
References
73
Citations by year
2026: 5 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 2
FWCI
0.97
Type
journal article
Language
en
Open access
Locations
  • Nature Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL136618, DK063491)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
idols, VLDLR, LDL receptor, E3 ubiquitin ligase, energy balance, diet-induced obesity, dietary intake, thermogenesis, hypothalamus, metabolic homeostasis, liver X receptor
MeSH terms
Animals, Blood Glucose, Diet, Energy Metabolism, Hypothalamus, Insulin Resistance, Neurons, Obesity, Receptors, LDL, Mice, Knockout, Ubiquitin-Protein Ligases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review